第一作者:
Lingling,Wang
第一单位:
Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Immunology, Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, China.
作者:
医学主题词
动物(Animals);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);自噬(Autophagy);碱性螺旋-环-螺旋转录因子类(Basic Helix-Loop-Helix Transcription Factors);结合部位(Binding Sites);乳腺肿瘤(Breast Neoplasms);癌, 导管, 乳腺(Carcinoma, Ductal, Breast);细胞增殖(Cell Proliferation);抗药性, 肿瘤(Drug Resistance, Neoplasm);雌激素受体α(Estrogen Receptor alpha);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);小鼠, SCID(Mice, SCID);肿瘤蛋白质类(Neoplasm Proteins);启动区, 遗传(Promoter Regions, Genetic);他莫昔芬(Tamoxifen);转录, 遗传(Transcription, Genetic);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays);小鼠(Mice)
DOI
10.1038/s41419-021-03442-z
PMID
33542201
发布时间
2024-03-30
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



